Ratings Summary for FEMARA

Overall Patient opinion of FEMARA: 2.5 (not satisfied)

(based on 1087 reviews ) (updated May 6, 2025)

Ratings by Age Group for FEMARA
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)
Age 18 to 24	7	1.4
Age 25 to 34	32	1.4
Age 35 to 44	84	2.7
Age 45 to 54	342	2.5
Age 55 to 64	468	2.5
Age 65 to 74	133	2.5
Age 75 and up	16	2.1

Ratings by Sex for FEMARA
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	20	2.5
Female	1047	2.56351480420248
Not Specified	20	2.45

Would you like to find reviews for FEMARA taken for a specific reason or resulting in a specific side effect?

Filter Results for FEMARA

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for FEMARA

Check here for Ask a Patient's Adverse Event Summary for FEMARA based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

FEMARA (LETROZOLE): This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. FDA Approval Date: 1997-07-25 (Sources: U.S. Centers for Medicare Services, FDA)

Patient Counseling Information from Official Drug Label

The above Patient Counseling and/or Medication Guide for FEMARA is from the official drug label (including Section 17) obtained from the National Library of Medicine's DailyMed database.
Please refer to the complete label here Official Drug Label for FEMARA.